MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Tremor Predominant Presentation Of DYT-TOR1A

    R. Kaur, A. Saini, R. Rajan, D. Garg, A. Elavarasi, A. Das, A. Srivastava, D. Radhakrishnan (New Delhi, India)

    Objective: To present a case report of a patient exhibiting tremors as the primary manifestation of DYT-TOR1A at onset, along with a review of the…
  • 2025 International Congress

    National Survey of DYT/PARK-GCH1 (Segawa Disease) in Japan

    K. Hoshino, M. Kawai, Y. Nagao, M. Nozaki, Y. Yatomi, Y. Hirano, M. Fukumizu, I. Kawahata, H. Shintaku, K. Kimura, M. Hayashi (Osaka, Japan)

    Objective: To clarify clinical features of Segawa Disease (SD) in Japan. Background: Prof Segawa discovered SD 50 years ago, and GCH-1 gene mutations were linked…
  • 2025 International Congress

    Molecular Studies Reveal Overactive Interferon (IFN) Pathway in Two Monogenic Inherited Dystonia Types.

    S. Avula, E. Swager, R. Patel (Columbia, USA)

    Objective: Our overall objective was to investigate the involvement of type I interferons (IFNs) in DYT-PRKRAand DYT-EIF2AK2. IFNs are antiviral cytokines produced by all cell…
  • 2025 International Congress

    Tracking Physiological Biomarker Activity in the Globus Pallidus Internus in Two Dystonia Patients Implanted with Medtronic Percept™

    S. Alberico, M. Berns, B. Pereira Rios, J. Aman, M. Park, D. Darrow, J. Vitek, L. Almeida (Minneapolis, USA)

    Objective: Explore potential biomarkers in dystonia patients implanted with Medtronic Percept™. Background: Though highly variable in presentation and underlying cause, individuals with dystonia present with…
  • 2025 International Congress

    Cerebellar connectivity predicts early response to GPi-DBS in dystonia.

    A. Martinez Nunez, V. Chandra, C. Fleeting, A. Patel, A. Fusco, J. Wong (Gainesville, USA)

    Objective: To investigate the structural and functional connectivity of patients who respond early after deep brain stimulation (DBS) for dystonia. Background: DBS is an effective…
  • 2025 International Congress

    Cerebrotendinous Xanthomatosis successfully treated with Chenodeoxycholic Acid Supplementation

    N. de Jong, J. Carr, D. Marais (Cape Town, South Africa)

    Objective: To describe the clinical, radiological, laboratory and genetic findings of a patient with Cerebrotendinous Xanthomatosis (CTX) who presented with dystonic tremor initially and subsequently…
  • 2025 International Congress

    Updates on Perception of Patients with Cervical Dystonia in Residents and Medical Students

    M. Patel, D. Talkington, D. Sblendorio, K. Pyle, M. Coleman, P. Sheehan, A. Memon, M. Moreno-Escobar, A. Murray, G. Pawar, J. Frey (Morgantown, USA)

    Objective: To determine if an educational intervention can reduce external stigma of patients with cervical dystonia (CD) in medical trainees. Background: Medical trainees may or…
  • 2025 International Congress

    Equity in Access to MRI-Guided Focused Ultrasound for Movement Disorders: Patient Characteristics and Treatment Disposition

    M. Park, D. Gonzalez, N. Pertsch, K. Sakakura, C. Swan, M. Wodziak, D. Ulrich, A. Karstens (Chicago, USA)

    Objective: To probe the characteristics of individuals undergoing MRI-guided focused ultrasound (MRgFUS). Background: MRgFUS has emerged as a non-invasive treatment that alleviates tremor through targeted…
  • 2025 International Congress

    Hair Glucocorticoids and Functional Movement Disorders Insights from a Cross Sectional Study

    VI. Lopez-Diaz, CA. Diaz-Garza, D. León Rojas, F. Luna-Rangel, M. González-González, J. Rodriguez-de-Ita, F. Castorena Torres, D. Martínez-Ramírez (Monterrey, Mexico)

    Objective: To compare hair glucocorticoid levels between patients with Functional Movement Disorders (FMD) and healthy controls. Background: FMD are complex neurological conditions that lack specific…
  • 2025 International Congress

    Severe Anti-NMDAR Encephalitis After the Covid 19 Cross-vaccination in three young women

    K. Methawasin, P. Tungkiatsilp, C. Suthamdireklap, M. Jaisa-Aad (Nakhon Nayok, Thailand)

    Objective: To describe three severe cases of anti-NMDAR encephalitis in young females after the COVID-19 cross-vaccination. Background: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is the most recognized…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley